Published in J Virol on June 01, 1998
Enhancer requirement for murine cytomegalovirus growth and genetic complementation by the human cytomegalovirus enhancer. J Virol (1998) 1.56
Role of the cytomegalovirus major immediate early enhancer in acute infection and reactivation from latency. Med Microbiol Immunol (2007) 1.20
Rat cytomegalovirus major immediate-early enhancer switching results in altered growth characteristics. J Virol (2001) 0.92
Differentiation-Coupled Induction of Human Cytomegalovirus Replication by Union of the Major Enhancer Retinoic Acid, Cyclic AMP, and NF-κB Response Elements. J Virol (2015) 0.77
A temporal gate for viral enhancers to co-opt Toll-like-receptor transcriptional activation pathways upon acute infection. PLoS Pathog (2015) 0.76
Estrogen-related receptor α is required for efficient human cytomegalovirus replication. Proc Natl Acad Sci U S A (2014) 0.75
Infection homeostasis: implications for therapeutic and immune programming of metabolism in controlling infection. Med Microbiol Immunol (2015) 0.75
A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature (1995) 11.18
A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell (1996) 11.02
A decade of molecular biology of retinoic acid receptors. FASEB J (1996) 9.70
Sequence-specific binding of glucocorticoid receptor to MTV DNA at sites within and upstream of the transcribed region. Cell (1983) 6.01
Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature (1995) 3.90
Dexamethasone-mediated induction of mouse mammary tumor virus RNA: a system for studying glucocorticoid action. Cell (1975) 3.44
Characterization of an autoregulated response element in the mouse retinoic acid receptor type beta gene. Proc Natl Acad Sci U S A (1990) 3.17
A deletion mutant in the human cytomegalovirus gene encoding IE1(491aa) is replication defective due to a failure in autoregulation. Proc Natl Acad Sci U S A (1996) 3.14
Molecular phylogeny and evolutionary timescale for the family of mammalian herpesviruses. J Mol Biol (1995) 2.84
A long and complex enhancer activates transcription of the gene coding for the highly abundant immediate early mRNA in murine cytomegalovirus. Proc Natl Acad Sci U S A (1985) 2.74
Peripheral blood mononuclear phagocytes mediate dissemination of murine cytomegalovirus. J Virol (1994) 2.52
Regulation of retinoid signalling by receptor polarity and allosteric control of ligand binding. Nature (1994) 2.43
The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic mice. J Virol (1996) 2.37
Cytomegalovirus replicates in differentiated but not in undifferentiated human embryonal carcinoma cells. Science (1984) 2.34
Insertional mutagenesis of the murine cytomegalovirus genome: one prominent alpha gene (ie2) is dispensable for growth. Virology (1988) 2.17
Transcriptional regulation of the human cytomegalovirus major immediate-early gene is associated with induction of DNase I-hypersensitive sites. Mol Cell Biol (1986) 2.05
Constitutive and retinoic acid-inducible expression of cytomegalovirus immediate-early genes in human teratocarcinoma cells. J Virol (1986) 1.69
Histone acetyltransferases in control. Curr Biol (1997) 1.68
Functional interaction of nuclear factors EF-C, HNF-4, and RXR alpha with hepatitis B virus enhancer I. J Virol (1993) 1.58
Murine cytomegalovirus IE2, an activator of gene expression, is dispensable for growth and latency in mice. Virology (1995) 1.44
A retinoic acid receptor alpha antagonist selectively counteracts retinoic acid effects. Proc Natl Acad Sci U S A (1992) 1.36
Human cytomegalovirus (HCMV) immediate-early enhancer/promoter specificity during embryogenesis defines target tissues of congenital HCMV infection. J Virol (1995) 1.27
Developmental analysis of the cytomegalovirus enhancer in transgenic animals. J Virol (1996) 1.27
Splenic necrosis in mice infected with cytomegalovirus. J Infect Dis (1978) 1.25
Retinoic acid receptors initiate induction of the cytomegalovirus enhancer in embryonal cells. Proc Natl Acad Sci U S A (1992) 1.17
Identification and functional separation of retinoic acid receptor neutral antagonists and inverse agonists. J Biol Chem (1996) 1.10
Characterization of the sequences of the human cytomegalovirus enhancer that mediate differential regulation by natural and synthetic retinoids. Mol Endocrinol (1996) 1.07
Simian virus 40 late gene expression is regulated by members of the steroid/thyroid hormone receptor superfamily. Proc Natl Acad Sci U S A (1995) 1.07
Retinoid activation of retinoic acid receptors but not of retinoid X receptors promotes cellular differentiation and replication of human cytomegalovirus in embryonal cells. J Virol (1995) 1.04
AGN193109 is a highly effective antagonist of retinoid action in human ectocervical epithelial cells. J Biol Chem (1996) 1.04
Retinoic acid induction of major histocompatibility complex class I genes in NTera-2 embryonal carcinoma cells involves induction of NF-kappa B (p50-p65) and retinoic acid receptor beta-retinoid X receptor beta heterodimers. Mol Cell Biol (1993) 1.00
Synthesis and characterization of a highly potent and effective antagonist of retinoic acid receptors. J Med Chem (1995) 0.97
Synthesis of high specific activity [3H]-9-cis-retinoic acid and its application for identifying retinoids with unusual binding properties. J Med Chem (1994) 0.96
Direct modulation of simian virus 40 late gene expression by thyroid hormone and its receptor. J Virol (1997) 0.94
A steroid hormone response unit in the late leader of the noncoding control region of the human polyomavirus BK confers enhanced host cell permissivity. J Virol (1994) 0.91
Differences in the pharmacokinetic properties of orally administered all-trans-retinoic acid and 9-cis-retinoic acid in the plasma of nude mice. Drug Metab Dispos (1994) 0.91
Retinoid-induced epiphyseal plate closure in guinea pigs. Fundam Appl Toxicol (1996) 0.90
Principles of cytomegalovirus antigen presentation in vitro and in vivo. Semin Immunol (1992) 0.88
Regulation of human cytomegalovirus by retinoic acid. Scand J Infect Dis Suppl (1995) 0.85
Retinoid-induced hypertriglyceridemia in rats is mediated by retinoic acid receptors. Fundam Appl Toxicol (1996) 0.84
Specific antagonist of retinoid toxicity in mice. Toxicol Appl Pharmacol (1996) 0.80
A novel type of retinoic acid receptor antagonist: synthesis and structure-activity relationships of heterocyclic ring-containing benzoic acid derivatives. J Med Chem (1995) 0.79
Retinobenzoic acids. 6. Retinoid antagonists with a heterocyclic ring. J Med Chem (1994) 0.78
A novel class of retinoid antagonists and their mechanism of action. J Biol Chem (1996) 0.78
A retinoic acid receptor alpha antagonist counteracts retinoid teratogenicity in vitro and reduced incidence and/or severity of malformations in vivo. Toxicol Lett (1994) 0.78
Vitamin A Regulation of Viral Growth. Rev Med Virol (1997) 0.77
Human cytomegalovirus infection of kidney glomerular visceral epithelial and tubular epithelial cells in culture. Transplantation (1988) 0.76
Pharmacological and toxicological properties of arotinoids SMR-2 and SMR-6 in mice. Fundam Appl Toxicol (1990) 0.76
Promoter-specific trans activation and repression by human cytomegalovirus immediate-early proteins involves common and unique protein domains. J Virol (1990) 4.24
Human cytomegalovirus productively infects primary differentiated macrophages. J Virol (1991) 3.16
Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proc Natl Acad Sci U S A (1996) 3.16
Binding of transcription factors and creation of a large nucleoprotein complex on the human cytomegalovirus enhancer. Proc Natl Acad Sci U S A (1987) 2.89
Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP. Nature (2001) 2.84
DNA microarrays of the complex human cytomegalovirus genome: profiling kinetic class with drug sensitivity of viral gene expression. J Virol (1999) 2.80
The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic mice. J Virol (1996) 2.37
Synergy between medical informatics and bioinformatics: facilitating genomic medicine for future health care. J Biomed Inform (2004) 2.25
Hijacking and exploitation of IL-10 by intracellular pathogens. Trends Microbiol (2001) 2.03
Kinetic analysis of yeast TFIID-TATA box complex formation suggests a multi-step pathway. J Biol Chem (1992) 2.02
Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells. Cancer Res (1997) 1.96
Global analysis of herpes simplex virus type 1 transcription using an oligonucleotide-based DNA microarray. J Virol (2000) 1.95
Human cytomegalovirus IE86 protein interacts with promoter-bound TATA-binding protein via a specific region distinct from the autorepression domain. J Virol (1993) 1.82
Regulation and tissue-specific expression of human cytomegalovirus. Curr Top Microbiol Immunol (1990) 1.76
Direct interaction of the human cytomegalovirus IE86 protein with the cis repression signal does not preclude TBP from binding to the TATA box. J Virol (1993) 1.68
Murine cytomegalovirus infection down-regulates MHC class II expression on macrophages by induction of IL-10. J Immunol (1999) 1.62
The major immediate-early gene ie3 of mouse cytomegalovirus is essential for viral growth. J Virol (2000) 1.62
Annexation of the interchromosomal space during viral infection. Nat Cell Biol (2000) 1.59
Enhancer requirement for murine cytomegalovirus growth and genetic complementation by the human cytomegalovirus enhancer. J Virol (1998) 1.56
Cell-specific activity of the modulator region in the human cytomegalovirus major immediate-early gene. Mol Cell Biol (1989) 1.55
Retinoids inhibit proliferation of human coronary smooth muscle cells by modulating cell cycle regulators. Arterioscler Thromb Vasc Biol (2001) 1.54
An isoform variant of the cytomegalovirus immediate-early auto repressor functions as a transcriptional activator. Virology (1992) 1.51
Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin. J Invest Dermatol (1997) 1.50
Multiple left-right asymmetry defects in Shh(-/-) mutant mice unveil a convergence of the shh and retinoic acid pathways in the control of Lefty-1. Proc Natl Acad Sci U S A (1999) 1.43
Identification and characterization of a retinoid-induced class II tumor suppressor/growth regulatory gene. Proc Natl Acad Sci U S A (1998) 1.40
Lymphotoxins and cytomegalovirus cooperatively induce interferon-beta, establishing host-virus détente. Immunity (2001) 1.37
Sequence structures of a mouse major urinary protein gene and pseudogene compared. EMBO J (1985) 1.31
Retinoid signaling is required for chondrocyte maturation and endochondral bone formation during limb skeletogenesis. Dev Biol (1999) 1.31
Defective interleukin (IL)-18-mediated natural killer and T helper cell type 1 responses in IL-1 receptor-associated kinase (IRAK)-deficient mice. J Exp Med (1999) 1.30
Impaired immunoproteasome assembly and immune responses in PA28-/- mice. Science (1999) 1.29
Site-specific inhibition of RNA polymerase II preinitiation complex assembly by human cytomegalovirus IE86 protein. J Virol (1993) 1.28
Developmental analysis of the cytomegalovirus enhancer in transgenic animals. J Virol (1996) 1.27
Contributions of the TATA box sequence to rate-limiting steps in transcription initiation by RNA polymerase II. J Mol Biol (1998) 1.22
Retinoic acid receptor-beta: an endogenous inhibitor of the perinatal formation of pulmonary alveoli. Physiol Genomics (2000) 1.21
13-cis retinoic acid exerts its specific activity on human sebocytes through selective intracellular isomerization to all-trans retinoic acid and binding to retinoid acid receptors. J Invest Dermatol (2000) 1.21
Role of opportunistic viral infections in AIDS. AIDS (1990) 1.19
Forskolin inducibility and tissue-specific expression of the fibronectin promoter. Mol Cell Biol (1989) 1.19
Regulation of skeletal progenitor differentiation by the BMP and retinoid signaling pathways. J Cell Biol (2000) 1.18
Active repression of RAR signaling is required for head formation. Genes Dev (2001) 1.16
Improving data and knowledge management to better integrate health care and research. J Intern Med (2013) 1.15
Inhibition of the association of RNA polymerase II with the preinitiation complex by a viral transcriptional repressor. Proc Natl Acad Sci U S A (1996) 1.14
Therapeutic applications for ligands of retinoid receptors. Curr Pharm Des (2000) 1.13
Peroxisome proliferator-activated receptor and retinoid X receptor ligands inhibit monocyte chemotactic protein-1-directed migration of monocytes. Eur J Pharmacol (2000) 1.12
Endometrial inhibin/activin beta-B subunit expression is related to decidualization and is reduced in tubal ectopic pregnancy. J Clin Endocrinol Metab (2008) 1.11
Identification and functional separation of retinoic acid receptor neutral antagonists and inverse agonists. J Biol Chem (1996) 1.10
Identification and characterization of a versatile retinoid response element (retinoic acid receptor response element-retinoid X receptor response element) in the mouse tissue transglutaminase gene promoter. J Biol Chem (1996) 1.10
Molecular signatures for diagnosis of infection: application of microarray technology. J Appl Microbiol (2004) 1.08
Tazarotene-induced gene 1 (TIG1), a novel retinoic acid receptor-responsive gene in skin. J Invest Dermatol (1996) 1.08
Experiments using microarray technology: limitations and standard operating procedures. J Endocrinol (2003) 1.07
Retinoic acid receptor alpha expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status. Cancer Res (1997) 1.07
Characterization of the sequences of the human cytomegalovirus enhancer that mediate differential regulation by natural and synthetic retinoids. Mol Endocrinol (1996) 1.07
Generation of a transcription map at the HSD17B locus centromeric to BRCA1 at 17q21. Genomics (1995) 1.07
Endometrial cysteine-rich secretory protein 3 is inhibited by human chorionic gonadotrophin, and is increased in the decidua of tubal ectopic pregnancy. Mol Hum Reprod (2009) 1.06
Activation of retinoid X receptors induces apoptosis in HL-60 cell lines. Mol Cell Biol (1995) 1.05
Expression of a retinoid-inducible tumor suppressor, Tazarotene-inducible gene-3, is decreased in psoriasis and skin cancer. Clin Cancer Res (2000) 1.04
Retinoid activation of retinoic acid receptors but not of retinoid X receptors promotes cellular differentiation and replication of human cytomegalovirus in embryonal cells. J Virol (1995) 1.04
Evolutionary amplification of a pseudogene. Proc Natl Acad Sci U S A (1985) 1.04
AGN193109 is a highly effective antagonist of retinoid action in human ectocervical epithelial cells. J Biol Chem (1996) 1.04
Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells. Clin Cancer Res (2000) 1.04
Anti-repression of RNA polymerase II transcription by pyrrole-imidazole polyamides. Biochemistry (1999) 1.04
The carboxy-terminal hydrophobic domain of TIG3, a class II tumor suppressor protein, is required for appropriate cellular localization and optimal biological activity. Int J Oncol (2000) 1.03
Identification of highly potent retinoic acid receptor alpha-selective antagonists. J Med Chem (1997) 1.03
Rapid antibody responses by low-dose, single-step, dendritic cell-targeted immunization. Proc Natl Acad Sci U S A (2000) 1.01
Separation of transactivation and AP1 antagonism functions of retinoic acid receptor alpha. J Biol Chem (1995) 1.00
PDQ Wizard: automated prioritization and characterization of gene and protein lists using biomedical literature. Bioinformatics (2006) 1.00
Retinoid-dependent recruitment of a histone H1 displacement activity by retinoic acid receptor. J Biol Chem (1999) 1.00
Virogenomics: a novel approach to antiviral drug discovery. Drug Discov Today (2001) 0.99
Role of retinoic acid in lens regeneration. Dev Dyn (2000) 0.98
Evidence of a lysosomal pathway for apoptosis induced by the synthetic retinoid CD437 in human leukemia HL-60 cells. Cell Death Differ (2001) 0.98
Inhibition of the stress-activated kinase, p38, does not affect the virus transcriptional program of herpes simplex virus type 1. Virology (2004) 0.98
Synthesis and characterization of a highly potent and effective antagonist of retinoic acid receptors. J Med Chem (1995) 0.97
Immediate-early expression of the herpes simplex virus type 1 ICP27 transcript is not critical for efficient replication in vitro or in vivo. J Virol (2004) 0.96
Recruitment of nuclear receptor corepressor and coactivator to the retinoic acid receptor by retinoid ligands. Influence of DNA-heterodimer interactions. J Biol Chem (2000) 0.96
Retinoic acid alters the intracellular trafficking of the mannose-6-phosphate/insulin-like growth factor II receptor and lysosomal enzymes. Proc Natl Acad Sci U S A (1998) 0.94
Enantioselective syntheses of potent retinoid X receptor ligands: differential biological activities of individual antipodes. J Med Chem (2001) 0.94
Quantitative comparison of the HSV-1 and HSV-2 transcriptomes using DNA microarray analysis. Virology (2006) 0.93
Combinatorial image analysis of DNA microarray features. Bioinformatics (2003) 0.93
Recent developments in receptor-selective retinoids. Curr Pharm Des (2000) 0.92
Dimethyl sulfoxide blocks herpes simplex virus-1 productive infection in vitro acting at different stages with positive cooperativity. Application of micro-array analysis. BMC Infect Dis (2002) 0.92
Cell-specific activity of the human immunodeficiency virus enhancer repeat in vitro. AIDS Res Hum Retroviruses (1988) 0.92
Regulation of stearoyl coenzyme A desaturase expression in human retinal pigment epithelial cells by retinoic acid. J Biol Chem (2001) 0.92
Mannose 6-phosphate/insulin-like growth factor II receptor mediates the growth-inhibitory effects of retinoids. Cell Growth Differ (1999) 0.90
Vitamin A and regulation of gene expression. Curr Opin Clin Nutr Metab Care (1998) 0.90
Retinoid-induced epiphyseal plate closure in guinea pigs. Fundam Appl Toxicol (1996) 0.90
Steroid signalling in human ovarian surface epithelial cells: the response to interleukin-1alpha determined by microarray analysis. J Endocrinol (2004) 0.89
Identification of a retinoic acid receptor alpha subtype specific agonist. J Med Chem (1996) 0.89
Molecular mechanisms of tazarotene action in psoriasis. J Am Acad Dermatol (1997) 0.89
Differential responses of normal, premalignant, and malignant human bronchial epithelial cells to receptor-selective retinoids. Clin Cancer Res (1999) 0.88
Retinoic acid receptor-nuclear factor-interleukin 6 antagonism. A novel mechanism of retinoid-dependent inhibition of a keratinocyte hyperproliferative differentiation marker. J Biol Chem (1997) 0.87
Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor- and retinoic acid receptor-specific retinoids. Cell Growth Differ (1996) 0.87
23,25-Dihydroxy-24-oxovitamin D3: a metabolite of vitamin D3 made in the kidney. Biochemistry (1983) 0.86
Intraspecific evolution of a gene family coding for urinary proteins. J Mol Evol (1989) 0.86
Transplantation of a 17-amino acid alpha-helical DNA-binding domain into an antibody molecule confers sequence-dependent DNA recognition. Proc Natl Acad Sci U S A (1995) 0.85
Negative regulation of two hyperproliferative keratinocyte differentiation markers by a retinoic acid receptor-specific retinoid: insight into the mechanism of retinoid action in psoriasis. Cell Growth Differ (1996) 0.85
Regulation of human cytomegalovirus by retinoic acid. Scand J Infect Dis Suppl (1995) 0.85
Identification of a boundary domain adjacent to the potent human cytomegalovirus enhancer that represses transcription of the divergent UL127 promoter. J Virol (2000) 0.85
Immune checkpoints in viral latency. Annu Rev Microbiol (2001) 0.84